Torray Investment Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.01M Sell
4,141
-80
-2% -$18.6K 0.15% 66
2025
Q4
$874K Hold
4,221
0.13% 73
2025
Q3
$783K Hold
4,221
0.11% 77
2025
Q2
$645K Sell
4,221
-106,893
-96% -$16.4M 0.09% 79
2025
Q1
$18.4M Hold
111,114
2.75% 7
2024
Q4
$16.1M Sell
111,114
-150
-0.1% -$23.2K 2.3% 13
2024
Q3
$18M Buy
111,264
+23,902
+27% +$3.81M 2.52% 7
2024
Q2
$12.8M Hold
87,362
1.91% 21
2024
Q1
$13.8M Hold
87,362
2.07% 19
2023
Q4
$13.7M Buy
87,362
+10,472
+14% +$1.61M 2.22% 17
2023
Q3
$12M Buy
76,890
+150
+0.2% +$24.8K 2.11% 16
2023
Q2
$12.7M Hold
76,740
2.2% 17
2023
Q1
$11.9M Hold
76,740
2.13% 16
2022
Q4
$13.6M Hold
76,740
2.44% 9
2022
Q3
$12.5M Buy
76,740
+990
+1% +$168K 2.5% 10
2022
Q2
$13.4M Sell
75,750
-13,086
-15% -$2.33M 2.57% 10
2022
Q1
$15.7M Sell
88,836
-8,338
-9% -$1.42M 2.53% 9
2021
Q4
$16.6M Sell
97,174
-7,059
-7% -$1.16M 2.45% 7
2021
Q3
$16.8M Sell
104,233
-5,584
-5% -$953K 2.58% 10
2021
Q2
$18.1M Sell
109,817
-590
-0.5% -$97.7K 2.66% 4
2021
Q1
$18.1M Hold
110,407
2.84% 4
2020
Q4
$17.4M Buy
110,407
+43
+0% +$6.34K 2.86% 6
2020
Q3
$16.4M Sell
110,364
-2,250
-2% -$333K 3.02% 5
2020
Q2
$15.8M Sell
112,614
-777
-0.7% -$113K 2.98% 4
2020
Q1
$14.9M Buy
113,391
+1,119
+1% +$159K 3.28% 3
2019
Q4
$16.4M Sell
112,272
-111
-0.1% -$15.1K 2.82% 7
2019
Q3
$14.5M Sell
112,383
-135
-0.1% -$17.8K 1.58% 31
2019
Q2
$15.7M Buy
112,518
+90
+0.1% +$12.5K 1.63% 30
2019
Q1
$15.7M Sell
112,428
-852
-0.8% -$114K 1.66% 28
2018
Q4
$14.6M Buy
113,280
+8
+0% +$1.12K 1.73% 24
2018
Q3
$15.7M Sell
113,272
-62
-0.1% -$8.24K 1.56% 29
2018
Q2
$13.8M Sell
113,334
-452
-0.4% -$56.4K 1.44% 35
2018
Q1
$14.6M Buy
113,786
+21
+0% +$2.84K 1.51% 33
2017
Q4
$15.9M Sell
113,765
-3,399
-3% -$473K 1.57% 31
2017
Q3
$15.2M Buy
117,164
+2,869
+3% +$380K 1.51% 33
2017
Q2
$15.1M Buy
114,295
+163
+0.1% +$20.8K 1.59% 28
2017
Q1
$14.2M Buy
114,132
+646
+0.6% +$77.2K 1.49% 35
2016
Q4
$13.1M Buy
113,486
+228
+0.2% +$26.3K 1.39% 40
2016
Q3
$13.4M Sell
113,258
-500
-0.4% -$60.7K 1.47% 34
2016
Q2
$13.8M Buy
113,758
+605
+0.5% +$68.7K 1.05% 34
2016
Q1
$12.2M Sell
113,153
-200
-0.2% -$20.7K 0.64% 41
2015
Q4
$11.6M Buy
113,353
+155
+0.1% +$15.6K 0.86% 42
2015
Q3
$10.6M Sell
113,198
-1,320
-1% -$128K 0.78% 45
2015
Q2
$11.2M Buy
114,518
+108,095
+1,683% +$10.8M 0.73% 47
2015
Q1
$646K Sell
6,423
-106,960
-94% -$10.9M 0.08% 30
2014
Q4
$11.9M Buy
113,383
+1,659
+1% +$175K 1% 45
2014
Q3
$11.9M Hold
111,724
1.08% 45
2014
Q2
$11.7M Sell
111,724
-16,300
-13% -$1.65M 1.18% 46
2014
Q1
$12.6M Hold
128,024
2.13% 12
2013
Q4
$11.7M Sell
128,024
-380
-0.3% -$35K 2.43% 16
2013
Q3
$11.1M Sell
128,404
-37,895
-23% -$3.4M 2.4% 18
2013
Q2
$14.3M Buy
+166,299
New +$14.1M 3.11% 4

Other funds holding JNJ

Torray Investment Partners's JNJ Position: Q1 2026 in Review

Torray Investment Partners reduced its Johnson & Johnson (JNJ) stake by 1.9% in Q1 2026, selling an estimated $18.6K and leaving 4,141 shares worth $1.01M. The position accounts for 0.15% of the portfolio, ranked #66.

Torray Investment Partners first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $18.4M in Q1 2025. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Torray Investment Partners held 4,141 shares of Johnson & Johnson worth $1.01M as of Q1 2026.
  • Torray Investment Partners sold 80 Johnson & Johnson shares in Q1 2026, an estimated $18.6K.
  • Johnson & Johnson made up 0.15% of Torray Investment Partners's portfolio in Q1 2026, its #66 holding.
  • Torray Investment Partners first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Torray Investment Partners's Johnson & Johnson position peaked at $18.4M in Q1 2025.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Torray Investment Partners's 13F filing for Q1 2026, filed 1 May 2026.